|
| | Publication Year | Title | Author(s) |
| 1 | Jan-2024 | Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. | Hofman, Michael S; Emmett, Louise; Sandhu, Shahneen; Iravani, Amir; Buteau, James P; Joshua, Anthony M; Goh, Jeffrey C; Pattison, David A; Tan, Thean Hsiang; Kirkwood, Ian D; Ng, Siobhan; Francis, Roslyn J; Gedye, Craig; Rutherford, Natalie K; Weickhardt, Andrew J ; Scott, Andrew M ; Lee, Sze Ting ; Kwan, Edmond M; Azad, Arun A; Ramdave, Shakher; Redfern, Andrew D; Macdonald, William; Guminski, Alex; Hsiao, Edward; Chua, Wei; Lin, Peter; Zhang, Alison Yan; Stockler, Martin R; Williams, Scott G; Martin, Andrew J; Davis, Ian D |
| 2 | 2024 | A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies. | Lin, Chia-Chi; Garralda, Elena; Schöffski, Patrick; Hong, David S; Siu, Lillian L; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross A; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel Sw; Cassier, Philippe A; Sarantopoulos, John; Weickhardt, Andrew J ; Carvajal, Richard D; Spratlin, Jennifer; Esaki, Taito; Rolland, Fréderic; Akerley, Wallace; Deschler-Baier, Barbara; Rispoli, Lawrence; Samant, Tanay S; Chowdhury, Niladri Roy; Gusenleitner, Daniel; Kwak, Eunice L; Askoxylakis, Vasileios; De Braud, Filippo |
| 3 | Nov-2023 | Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations. | Conduit, Ciara; Lewin, Jeremy; Weickhardt, Andrew J ; Lynam, James; Wong, Shirley; Grimison, Peter; Sengupta, Shomik ; Pranavan, Ganes; Parnis, Francis; Bastick, Patricia; Campbell, David; Hansen, Aaron R; Leonard, Matt; McJannett, Margaret; Stockler, Martin R; Gibbs, Peter; Toner, Guy; Davis, Ian D; Tran, Ben; Kuchel, Anna |
| 4 | 6-Oct-2023 | Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502). | Weickhardt, Andrew J ; Foroudi, Farshad ; Lawrentschuk, Nathan; Xie, Jing; Sidhom, Mark; Pal, Abhijit; Grimison, Peter; Zhang, Alison; Ng, Siobhan; Tang, Colin; Hovey, Elizabeth; Chen, Colin; Hruby, George; Guminski, Alexander; McJannett, Margaret; Conduit, Ciara; Tran, Ben; Davis, Ian D; Hayne, Dickon |
| 5 | Oct-2023 | Narrative review of inpatient nutritional management of anorexia nervosa with management recommendations for Australian tertiary health services. | Hoo, Phoebe; Goldschlager, Romi; Katsoulis, John; Newnham, Evan; Harun, Nur-Shirin; Gwee, Karen; Silberberg, Carol; Russell, Nick; Lam, Simon K L ; Adithama, Esti; Cook, Natasha ; Weickhardt, Andrew J |
| 6 | 6-Sep-2023 | Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort. | Fernando, Michael; Anton, Angelyn; Weickhardt, Andrew J ; Azad, Arun A; Uccellini, Anthony; Brown, Stephen; Wong, Shirley; Parente, Phillip; Shapiro, Julia; Liow, Elizabeth; Torres, Javier; Goh, Jeffrey; Parnis, Francis; Steer, Christopher; Warren, Mark; Gibbs, Peter; Tran, Ben |
| 7 | 8-Jun-2023 | Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial. | Tremblay, Samuel; Alhogbani, Mofarej; Weickhardt, Andrew J ; Davis, Ian D; Scott, Andrew M ; Hicks, Rodney J; Metser, Ur; Chua, Sue; Davda, Reena; Punwani, Shonit; Payne, Heather; Tunariu, Nina; Ho, Bao; Young, Sympascho; Singbo, Mahukpe Narcisse Ulrich; Bauman, Glenn; Emmett, Louise; Pouliot, Frédéric |
| 8 | 2023 | Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancer. | Kelly, Richard; Jensen, Andrew; Karunaratna, Nathasha; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Parente, Phillip; Azad, Arun A; Uccellini, Anthony; Torres, Javier; Parnis, Francis; Goh, Jeffrey; Kwan, Edmond M; Brown, Stephen; Steer, Christopher; Warren, Mark; Gibbs, Peter; Tran, Ben; Anton, Angelyn |
| 9 | 2023 | Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter? | Pereira-Salgado, Amanda; Anton, Angelyn; Franchini, Fanny; Mahar, Robert K; Kwan, Edmond M; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun A; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Steer, Christopher; Brown, Stephen; Gibbs, Peter; Tran, Ben; IJzerman, Maarten |
| 10 | Jul-2022 | Pancreatic mass in a patient undergoing immunotherapy for metastatic renal cell carcinoma: dilemmas in management. | Goh, Su Kah ; Cox, Daniel R A ; Weickhardt, Andrew J ; Muralidharan, Vijayaragavan ; Perini, Marcos V |
| 11 | 1-Jun-2022 | Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma. | Navani, Vishal; Ernst, Matthew; Wells, J Connor; Yuasa, Takeshi; Takemura, Kosuke; Donskov, Frede; Basappa, Naveen S; Schmidt, Andrew ; Pal, Sumanta K; Meza, Luis; Wood, Lori A; Ernst, D Scott; Szabados, Bernadett; Powles, Thomas; McKay, Rana R; Weickhardt, Andrew J ; Suarez, Cristina; Kapoor, Anil; Lee, Jae Lyun; Choueiri, Toni K; Heng, Daniel Y C |
| 12 | 2-May-2022 | Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer. | Weickhardt, Andrew J ; Lau, David K ; Hodgson-Garms, Margeaux; Lavis, Austen; Jenkins, Laura J; Vukelic, Natalia; Ioannidis, Paul; Luk, Ian Y; Mariadason, John M |
| 13 | May-2022 | Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage. | Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon |
| 14 | Apr-2022 | Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial. | Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew J ; Ganju, Vinod; Joshua, Anthony M; Cavallo, Rosetta; Peng, Linda; Zhang, Xiaoyu; Kaul, Sanjeev; Baughman, Jan; Bonvini, Ezio; Moore, Paul A; Goldberg, Stacie M; Arnaldez, Fernanda I; Ferris, Robert L; Lakhani, Nehal J |
| 15 | 31-Mar-2022 | High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres. | Connolly, Elizabeth A; Weickhardt, Andrew J ; Grimison, Peter; Asher, Rebecca; Heller, Gillian Z; Lewin, Jeremy; Liow, Elizabeth; Toner, Guy; Tung, Iris L Y; Tran, Ben; Hill, Sean; Walpole, Euan; McKenzie, Jane; Kuchel, Anna; Goh, Jeffrey; Forgeson, Garry; Tan, Alvin; Joshi, Abhishek; Wickham, Alistair; Tan, Hsiang; Wang, Yang; Winstanley, Mark A; Hamad, Nada; Wong, Vanessa |
| 16 | Feb-2022 | Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. | Schöffski, Patrick; Tan, Daniel S W; Martín, Miguel; Ochoa-de-Olza, María; Sarantopoulos, John; Carvajal, Richard D; Kyi, Chrisann; Esaki, Taito; Prawira, Amy; Akerley, Wallace; De Braud, Filippo; Hui, Rina; Zhang, Tian; Soo, Ross A; Maur, Michela; Weickhardt, Andrew ; Krauss, Jürgen; Deschler-Baier, Barbara; Lau, Allen; Samant, Tanay S; Longmire, Tyler; Chowdhury, Niladri Roy; Sabatos-Peyton, Catherine A; Patel, Nidhi; Ramesh, Radha; Hu, Tiancen; Carion, Ana; Gusenleitner, Daniel; Yerramilli-Rao, Padmaja; Askoxylakis, Vasileios; Kwak, Eunice L; Hong, David S |
| 17 | 30-Jan-2022 | Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. | Chazan, Grace; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Gibbs, Peter; Tran, Ben |
| 18 | 24-Jan-2022 | VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. | Chionh, Fiona; Gebski, Val; Al-Obaidi, Sheren J; Mooi, Jennifer K ; Bruhn, Maressa A; Lee, Chee K; Chüeh, Anderly C; Williams, David S ; Weickhardt, Andrew J ; Wilson, Kate; Scott, Andrew M ; Simes, John; Hardingham, Jennifer E; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 19 | 14-Dec-2021 | Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer. | Anton, Angelyn; Pillai, Sruti; Semira, Marie Christine; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray ; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Baenziger, Olivia; Gibbs, Peter; Tran, Ben |
| 20 | Oct-2021 | Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer. | Kelly, Richard; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew J ; Azad, Arun; Kwan, Edmond Michael; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony; Pook, David; Baenziger, Olivia; Gibbs, Peter; Tran, Ben |
Loading...
2
0
20
0
false